This inventor holds 1 USPTO granted patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kensuke Nozaki: Innovator in Eye Health
Introduction
Kensuke Nozaki is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology, particularly in the treatment of presbyopia. His innovative approach has led to the development of a unique agent that addresses eye diseases.
Latest Patents
Kensuke Nozaki holds 1 patent for an agent containing 4-phenylbutyrate, aimed at preventing or treating presbyopia. This patent provides a formulation that includes 4-phenylbutyric acid or its esters, as well as pharmaceutically acceptable salts. The invention is designed to improve eye health and combat age-related vision issues.
Career Highlights
Nozaki is associated with Santen Pharmaceutical Co., Ltd., a leading company in the field of ophthalmic pharmaceuticals. His work at Santen has allowed him to focus on developing innovative solutions for eye care, contributing to advancements in the industry.
Collaborations
Throughout his career, Kensuke Nozaki has collaborated with notable colleagues, including Masatomo Kato and Tomoko Oda. These partnerships have fostered a collaborative environment that enhances research and development efforts in eye health.
Conclusion
Kensuke Nozaki's contributions to the field of ophthalmology, particularly through his patent for treating presbyopia, highlight his role as an innovator in eye health. His work continues to impact the lives of those affected by vision-related issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile